56 records, the earliest from 12 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
56 shown.
Sign in to see more, or upgrade your plan to see the full history.
Sign in
| Date | Category | Subject |
|---|
| 18 May 2018 16:31 | Delisting |
��Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957 , it has been decided to delist (withdraw the admission to dealings in) equity shares of the Plethico Pharmaceuticals Limited w.e.f. May 30, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009. |
| 28 Feb 2018 13:16 | Public Notice - Compulsory Delisting |
Members of the Exchange are hereby informed that the Exchange on February 28, 2018 has issued public notice in the newspaper for�� proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements). |
| 10 May 2016 10:46 | Resignation |
Plethico Pharmaceuticals Limited has informed the Exchange that the Company has received a resignation letter from the Director Ms Meena Matani. |
| 18 Apr 2016 07:02 | Disc. under Reg.30 of SEBI (SAST) Reg.2011 |
Shashikant A. Patel has submitted to the Exchange vide letter dated April 07, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. |
| 28 Mar 2016 11:01 | Updates |
Plethico Pharmaceuticals Limited has informed the Exchange that With a view to address the delay in repayment of principal and interest on fixed deposits, service banking facilities, pay statutory dues and sustain its business operations, the Company has opted to adopt contract manufacturing model for its operation. |
| 15 Mar 2016 04:43 | Financial Result Updates |
Plethico Pharmaceuticals Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2015. |
| 8 Mar 2016 10:23 | Trading Window |
Plethico Pharmaceuticals Limited has informed the Exchange that the Trading Window for the equity shares of the Company shall remain closed from March 9, 2016 to March 16, 2016 (both days inclusive) . lnter-alia to consider and approve the audited financial results for the quarter and year ended March 31, 2015.Accordingly, all the insiders and Designated Persons (including directors and employees) and others who have come in to the receipt of any insider information are hereby directed not to deal in shares of he Company during the period of closure of Trading Window as stated above. |
| 5 Feb 2016 12:25 | Change in Director(s) |
Plethico Pharmaceuticals Limited has informed the Exchange regarding appointment and resignation of Whole Time Director and Reconstitution of the Committee. |
| 4 Feb 2016 08:00 | Updates |
Plethico Pharmaceuticals Limited has informed the Exchange regarding the details of authorized Key Managerial Personnel for the purpose of determining materiality of an event or information and for the purpose of making disclosures to the Stock Exchanges. |
| 14 Jan 2016 11:19 | Outcome of Board Meeting |
Plethico Pharmaceuticals Limited has informed the Exchange about the Intimation of Appointment of Director and Rename and Reconstitution of the Committee |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
